SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

NCT00331864 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
531
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis